Taro Pharmaceutical Industries Ltd (TARO)
42.39
+0.09
(+0.21%)
USD |
NYSE |
May 20, 10:35
Taro Pharmaceutical Industries Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | -6.615M |
June 30, 2021 | -18.32M |
March 31, 2021 | -20.95M |
December 31, 2020 | -3.243M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | -0.157M |
December 31, 2019 | -26.83M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -16.66M |
December 31, 2018 | -539.79M |
September 30, 2018 | -7.749M |
June 30, 2018 | -24.66M |
March 31, 2018 | -52.06M |
December 31, 2017 | -14.50M |
Date | Value |
---|---|
September 30, 2017 | -31.93M |
June 30, 2017 | -8.489M |
March 31, 2017 | -25.18M |
December 31, 2016 | -29.09M |
September 30, 2016 | -108.13M |
June 30, 2016 | -132.49M |
March 31, 2016 | -9.45M |
December 31, 2015 | -5.439M |
September 30, 2015 | -0.226M |
June 30, 2015 | -0.223M |
March 31, 2015 | -0.219M |
December 31, 2014 | -10.30M |
September 30, 2014 | -0.20M |
June 30, 2014 | -0.196M |
March 31, 2014 | -0.087M |
December 31, 2013 | -203.77M |
September 30, 2013 | 0.272M |
June 30, 2013 | 0.122M |
March 31, 2013 | 1.351M |
December 31, 2012 | -8.949M |
September 30, 2012 | 0.653M |
June 30, 2012 | 3.619M |
December 31, 2011 | -10.71M |
September 30, 2011 | -0.67M |
June 30, 2011 | -3.659M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-26.83M
Minimum
Dec 2019
--
Maximum
Jun 2019
-4.006M
Average
--
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
InspireMD Inc | 0.00 |
BiomX Inc | -1.324M |
Alpha Tau Medical Ltd | -- |
Pluri Inc | 0.00 |
Holdco Nuvo Group DG Ltd | -- |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 30.92M |
Cash from Investing (Quarterly) | 81.67M |
Free Cash Flow | 86.00M |
Free Cash Flow Per Share (Quarterly) | -0.0945 |
Free Cash Flow to Equity (Quarterly) | -3.553M |
Free Cash Flow to Firm (Quarterly) | -3.553M |
Free Cash Flow Yield | 5.40% |